lintur vanddispergerbart granulat
syngenta nordics a/s - dicamba, triasulfuron - vanddispergerbart granulat - 659 g/kg dicamba ; 41 g/kg triasulfuron
nautius vanddispergerbart granulat
rotam agrochemical europe limited - tribenuron-methyl, tribenuron, thifensulfuron-methyl, thifensulfuron - vanddispergerbart granulat - 150 g/kg tribenuron-methyl ; (~ 145 g/kg tribenuron ; 400 g/kg thifensulfuron-methyl ; (~ 386 g/kg thifensulfuron
nuance wg vanddispergerbart granulat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - tribenuron-methyl, tribenuron - vanddispergerbart granulat - 750 g/kg tribenuron-methyl ; (~ 723 g/kg tribenuron
trimmer 500 wg vanddispergerbart granulat
adama northern europe b.v. - tribenuron-methyl, tribenuron - vanddispergerbart granulat - 500 g/kg tribenuron-methyl ; (~ 482 g/kg tribenuron
zoom vanddispergerbart granulat
syngenta nordics a/s - dicamba, triasulfuron - vanddispergerbart granulat - 600 g/kg dicamba ; 30 g/kg triasulfuron
lfs metsulfuron-methyl minigranulat
lfs kemi - metsulfuron-methyl, metsulfuron - minigranulat - 200 g/kg metsulfuron-methyl ; (~ 193 g/kg metsulfuron
risperidone "teva gmbh" 50 mg pulver og solvens til depotinjektionsvæske, suspension
teva gmbh - risperidon - pulver og solvens til depotinjektionsvæske, suspension - 50 mg
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - clopidogrel besilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotiske midler - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segment elevation akut myokardieinfarkt, i kombination med asa i medicinsk behandlede patienter, der er berettiget til trombolytisk terapi. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. for yderligere oplysninger henvises der til afsnit 5.